Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,63 USD | +1,98% | +6,44% | -26,16% |
Vakgebied
Aantal werknemers: 136
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 01-01-17 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 01-09-14 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-17 |
Mike Hassman
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-18 |
Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 01-01-14 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 21-11-17 |
John Tucker
CEO | Chief Executive Officer | 61 | 01-01-17 |
Frederick Hudson
BRD | Director/Board Member | 78 | 19-06-18 |
William Abraham
BRD | Director/Board Member | 64 | 16-02-21 |
Jack Khattar
CHM | Chairman | 62 | 12-07-16 |
Mette Agger
BRD | Director/Board Member | 59 | 01-03-14 |
Director/Board Member | 76 | 24-07-18 | |
Sara Bonstein
BRD | Director/Board Member | 43 | 08-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 054 409 | 31 343 287 ( 86,93 %) | 0 | 86,93 % |
Bedrijfsgegevens
scPharmaceuticals, Inc.
25 Burlington Mall Road Suite 203
01830, Burlington
+617 517 0730
http://www.scpharmaceuticals.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,16% | 164 mln. | |
+30,22% | 699 mld. | |
+25,07% | 571 mld. | |
-4,66% | 364 mld. | |
+18,37% | 326 mld. | |
+2,87% | 286 mld. | |
+14,68% | 236 mld. | |
+4,71% | 198 mld. | |
-12,43% | 194 mld. | |
-3,32% | 154 mld. |
- Beurs
- Aandelen
- Koers SCPH
- Onderneming scPharmaceuticals Inc.